Akero Therapeutics Inc’s recently made public that its Chief Operating Officer Young Jonathan unloaded Company’s shares for reported $0.28 million on Jan 02 ’25. In the deal valued at $28.03 per share,10,000 shares were sold. As a result of this transaction, Young Jonathan now holds 218,083 shares worth roughly $4.94 million.
Then, Jonathan Young bought 70,000 shares, generating $1,947,400 in total proceeds.
Before that, Lamy Patrick sold 1,000 shares. Akero Therapeutics Inc shares valued at $29,130 were divested by the Senior VP, Commercial Strategy at a price of $29.13 per share. As a result of the transaction, Lamy Patrick now holds 34,258 shares, worth roughly $0.78 million.
Citigroup initiated its Akero Therapeutics Inc [AKRO] rating to a Buy in a research note published on November 18, 2024; the price target was $65. Cantor Fitzgerald began covering AKRO with “an Overweight” recommendation on September 19, 2023. UBS started covering the stock on August 28, 2023. It rated AKRO as “a Buy”.
Price Performance Review of AKRO
On Monday, Akero Therapeutics Inc [NASDAQ:AKRO] saw its stock fall -8.90% to $22.63. Over the last five days, the stock has lost -19.87%. Akero Therapeutics Inc shares have fallen nearly -18.66% since the year began. Nevertheless, the stocks have fallen -3.04% over the past one year. While a 52-week high of $37.00 was reached on 01/06/25, a 52-week low of $15.32 was recorded on 01/13/25. SMA at 50 days reached $30.09, while 200 days put it at $25.94.
Levels Of Support And Resistance For AKRO Stock
The 24-hour chart illustrates a support level at 21.81, which if violated will result in even more drops to 21.00. On the upside, there is a resistance level at 23.99. A further resistance level may holdings at 25.36. The Relative Strength Index (RSI) on the 14-day chart is 23.02, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.84, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.37%. Stochastics %K at 5.49% indicates the stock is a buying.
How much short interest is there in Akero Therapeutics Inc?
A steep rise in short interest was recorded in Akero Therapeutics Inc stocks on 2024-12-13, dropping by -0.33 million shares to a total of 3.3 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 3.62 million shares. There was a decline of -9.89%, which implies that there is a negative sentiment for the stock.
